Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity

Kang Ho Kim, Gha Young Lee, Jong In Kim, Jong In Kim, Mira Ham, Joo Won Lee, Jae Bum Kim, Jae Bum Kim

Journal of Lipid Research · 2010 · 57 citations · 41 references

DOIFull text

Open access

Concepts

Abstract

Liver X receptor (LXR), a sterol-activated nuclear hormone receptor, has been implicated in cholesterol and fatty acid homeostasis via regulation of reverse cholesterol transport and de novo fatty acid synthesis. LXR is also involved in immune responses, including anti-inflammatory action and T cell proliferation. In this study, we demonstrated that activated LXR suppresses cell cycle progression and proliferation in certain cell types. Stimulation of LXR with synthetic ligand T0901317 or GW3965 inhibited cell growth rate and arrested the cell cycle at the G1/S boundary in several cells, such as RWPE1, THP1, SNU16, LNCaP, and HepG2. However, LXR ligands did not exhibit antiproliferative activity in PC3, HEK293, or HeLa cells. Interestingly, activated LXR-mediated cell cycle arrest is closely correlated with the lipogenic gene expression and triacylglyceride accumulation. In accordance with these findings, suppression of FAS via small-interference RNA (siRNA) partially alleviated the antiproliferative effect of LXR activation in RWPE1 cells. Together, these data suggest that LXR activation with its ligands inhibits cell proliferation and induces G1/S arrest through elevated lipogenic activity, thus proposing a novel effect of activated LXR on cell cycle regulation. Liver X receptor (LXR), a sterol-activated nuclear hormone receptor, has been implicated in cholesterol and fatty acid homeostasis via regulation of reverse cholesterol transport and de novo fatty acid synthesis. LXR is also involved in immune responses, including anti-inflammatory action and T cell proliferation. In this study, we demonstrated that activated LXR suppresses cell cycle progression and proliferation in certain cell types. Stimulation of LXR with synthetic ligand T0901317 or GW3965 inhibited cell growth rate and arrested the cell cycle at the G1/S boundary in several cells, such as RWPE1, THP1, SNU16, LNCaP, and HepG2. However, LXR ligands did not exhibit antiproliferative activity in PC3, HEK293, or HeLa cells. Interestingly, activated LXR-mediated cell cycle arrest is closely correlated with the lipogenic gene expression and triacylglyceride accumulation. In accordance with these findings, suppression of FAS via small-interference RNA (siRNA) partially alleviated the antiproliferative effect of LXR activation in RWPE1 cells. Together, these data suggest that LXR activation with its ligands inhibits cell proliferation and induces G1/S arrest through elevated lipogenic activity, thus proposing a novel effect of activated LXR on cell cycle regulation. Liver X receptor (LXR)α and LXRβ, also known as NR1H3 and NR1H2, respectively, are members of a nuclear hormone receptor superfamily, which are implicated in metabolic homeostasis and inflammation (1Steffensen K.R. Gustafsson J.A. Putative metabolic effects of the liver X receptor (LXR).Diabetes. 2004; 53: S36-S42Crossref PubMed Google Scholar). LXRα is highly expressed in several tissues, such as liver, adipose, and steroidogenic tissues, whereas LXRβ is expressed ubiquitously (2Annicotte J.S. Schoonjans K. Auwerx J. Expression of the liver X receptor alpha and beta in embryonic and adult mice.Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 2004; 277: 312-316Crossref PubMed Scopus (70) Google Scholar). LXR can be activated by certain oxygenated cholesterol derivatives, including 20(S)-hydroxycholesterol [20(S)-HC], 22(R)-HC, and 24HC, naturally occurring oxysterols that stimulate the expression of LXR target genes (3Janowski B.A. Willy P.J. Devi T.R. Falck J.R. Mangelsdorf D.J. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha.Nature. 1996; 383: 728-731Crossref PubMed Scopus (1476) Google Scholar). For example, ATP-binding cassette transporter (ABC)A1, ABCG1, ABCG5, apolipoprotein (apo)E, cytochrome P-450 7A1 (CYP7A1), sterol response element binding protein 1c (SREBP1c), and fatty acid synthase (FAS) are directly upregulated by activated LXR, consistent with key roles in the regulation of cholesterol and lipid metabolism (1Steffensen K.R. Gustafsson J.A. Putative metabolic effects of the liver X receptor (LXR).Diabetes. 2004; 53: S36-S42Crossref PubMed Google Scholar). In the liver and intestine, LXR activation has been reported to regulate cholesterol homeostasis through the expression of certain target genes, such as CYP7A1 and ABCG5/8, which are responsible for cholesterol conversion into bile acid and excretion (4Peet D.J. Turley S.D. Ma W. Janowski B.A. Lobaccaro J.M. Hammer R.E. Mangelsdorf D.J. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha.Cell. 1998; 93: 693-704Abstract Full Text Full Text PDF PubMed Scopus (1252) Google Scholar, 5Repa J.J. Mangelsdorf D.J. The liver X receptor gene team: potential new players in atherosclerosis.Nat. Med. 2002; 8: 1243-1248Crossref PubMed Scopus (341) Google Scholar, 6Naik S.U. Wang X. Da Silva J.S. Jaye M. Macphee C.H. Reilly M.P. Billheimer J.T. Rothblat G.H. Rader D.J. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.Circulation. 2006; 113: 90-97Crossref PubMed Scopus (314) Google Scholar, 7Plosch T. Kok T. Bloks V.W. Smit M.J. Havinga R. Chimini G. Groen A.K. Kuipers F. Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1.J. Biol. Chem. 2002; 277: 33870-33877Abstract Full Text Full Text PDF PubMed Scopus (176) Google Scholar). Furthermore, activated LXR promotes the expression of several genes involved in cholesterol efflux, such as ABCA1, ABCG1, and apoE, to stimulate a reverse cholesterol transport from macrophage to liver (5Repa J.J. Mangelsdorf D.J. The liver X receptor gene team: potential new players in atherosclerosis.Nat. Med. 2002; 8: 1243-1248Crossref PubMed Scopus (341) Google Scholar). Consistent with these findings, LXR activation shows an anti-atherogenic effect in Ldlr and apoE knockout mice (8Ohashi R. Mu H. Yao Q. Chen C. Cellular and molecular mechanisms of atherosclerosis with mouse models.Trends Cardiovasc. Med. 2004; 14: 187-190Crossref PubMed Scopus (36) Google Scholar). Deletion of LXRα results in impaired cholesterol and bile acid metabolism in the liver, which increases peripheral cholesterol accumulation and leads to atherosclerosis (4Peet D.J. Turley S.D. Ma W. Janowski B.A. Lobaccaro J.M. Hammer R.E. Mangelsdorf D.J. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha.Cell. 1998; 93: 693-704Abstract Full Text Full Text PDF PubMed Scopus (1252) Google Scholar, 9Tangirala R.K. Bischoff E.D. Joseph S.B. Wagner B.L. Walczak R. Laffitte B.A. Daige C.L. Thomas D. Heyman R.A. Mangelsdorf D.J. et al.Identification of macrophage liver X receptors as inhibitors of atherosclerosis.Proc. Natl. Acad. Sci. USA. 2002; 99: 11896-11901Crossref PubMed Scopus (375) Google Scholar). Therefore, one of the key functions of LXR has been implicated in atherosclerosis and its related metabolic complications. LXR activation governs not only cholesterol homeostasis but also fatty acid metabolism. For example, administration of T0901317, a synthetic LXR ligand, leads to hepatic steatosis and hypertriglyceridemia through the enhancement of de novo fatty acid synthesis, which is accomplished by the induction of key lipogenic genes, such as SREBP1c and FAS (10Darimont C. Avanti O. Zbinden I. Leone-Vautravers P. Mansourian R. Giusti V. Mace K. Liver X receptor preferentially activates de novo lipogenesis in human preadipocytes.Biochimie. 2006; 88: 309-318Crossref PubMed Scopus (46) Google Scholar, 11Joseph S.B. Laffitte B.A. Patel P.H. Watson M.A. Matsukuma K.E. Walczak R. Collins J.L. Osborne T.F. Tontonoz P. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors.J. Biol. Chem. 2002; 277: 11019-11025Abstract Full Text Full Text PDF PubMed Scopus (626) Google Scholar, 12Yoshikawa T. Shimano H. Amemiya-Kudo M. Yahagi N. Hasty A.H. Matsuzaka T. Okazaki H. Tamura Y. Iizuka Y. Ohashi K. et al.Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter.Mol. Cell. Biol. 2001; 21: 2991-3000Crossref PubMed Scopus (435) Google Scholar). Furthermore, it has been reported that chronic activation of LXR contributes to lipotoxicity and apoptosis in pancreatic β-cells through hyperactivation of lipogenesis (13Choe S.S. Choi A.H. Lee J.W. Kim K.H. Chung J.J. Park J. Lee K.M. Park K.G. Lee I.K. Kim J.B. Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic beta-cells.Diabetes. 2007; 56: 1534-1543Crossref PubMed Scopus (83) Google Scholar). Due to unwanted potent lipogenic effect of T0901317, GW3965, another LXR ligand, has been developed (14Collins J.L. Fivush A.M. Watson M.A. Galardi C.M. Lewis M.C. Moore L.B. Parks D.J. Wilson J.G. Tippin T.K. Binz J.G. et al.Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines.J. Med. Chem. 2002; 45: 1963-1966Crossref PubMed Scopus (371) Google Scholar). GW3965 exhibits a much milder effect on lipogenic activity of LXR, even though GW3965 selectively activates LXR to maintain cholesterol efflux. Recently, other roles of LXR have been reported. Activation of LXR suppresses innate immunity by inhibiting the expression of inflammatory genes, such as inducible nitric oxide synthase (iNOS), cyclooxygenase 2 (COX2), and interleukin-6 (IL6), in response to bacterial infection or lipopolysaccharide (LPS) stimulation (15Joseph S.B. Castrillo A. Laffitte B.A. Mangelsdorf D.J. Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors.Nat. Med. 2003; 9: 213-219Crossref PubMed Scopus (1015) Google Scholar, 16Joseph S.B. Bradley M.N. Castrillo A. Bruhn K.W. Mak P.A. Pei L. Hogenesch J. O'Connell R.M. Cheng G. Saez E. et al.LXR-dependent gene expression is important for macrophage survival and the innate immune response.Cell. 2004; 119: 299-309Abstract Full Text Full Text PDF PubMed Scopus (453) Google Scholar). Moreover, LXRα/β-null macrophages reveal enhanced apoptosis after microbial infection due to defects of LXR-dependent target gene expression, implying that LXR would be important for macrophage survival and innate immune response (16Joseph S.B. Bradley M.N. Castrillo A. Bruhn K.W. Mak P.A. Pei L. Hogenesch J. O'Connell R.M. Cheng G. Saez E. et al.LXR-dependent gene expression is important for macrophage survival and the innate immune response.Cell. 2004; 119: 299-309Abstract Full Text Full Text PDF PubMed Scopus (453) Google Scholar). Several reports suggest that LXR is involved in proliferation of several cell types, such as smooth muscle cell, insulin-secreting MIN6 cell, and prostate-originated cancer cell lines (17Blaschke F. Leppanen O. Takata Y. Caglayan E. Liu J. Fishbein M.C. Kappert K. Collins E. et X receptor smooth muscle cell proliferation and in 2004; PubMed Google Scholar, W. H. J. A.M. Activation of liver X receptors and X receptors induces growth arrest and apoptosis in insulin-secreting 2007; PubMed Scopus Google Scholar, R.A. J.M. J. Chen of growth and progression of cancer in mice by and liver X receptor 2006; PubMed Scopus Google Scholar, J. J.M. R.A. effect of liver X receptor on human cancer 2004; PubMed Scopus Google Scholar, J. J.J. L. X. Activation of liver X receptors inhibits pancreatic beta cell proliferation through cell cycle PubMed Scopus Google Scholar). it has been reported that LXR activation is with regulation of and the molecular is for cell cycle regulation. In the study, we have the effect of activated LXR on cell proliferation. Activation of LXR by its ligands G1/S arrest and cell proliferation in certain cells, such as RWPE1, THP1, LNCaP, and cells, but not in PC3, and cells. the molecular mechanisms that are with cell cycle data suggest that lipogenic activity of activated LXR is important for the of cell proliferation and cell cycle T0901317 and GW3965 from and and acid by acid in to into the at for 2 and to as M. M. H. R. by inhibits activation by 2003; Full Text Full Text PDF PubMed Scopus Google Scholar, A.H. M. M. A of expression by in human Biol. 2002; PubMed Scopus Google Scholar). RWPE1, LNCaP, and a from of cell in a as RWPE1 in with human and and in with in alpha with in with in with and HeLa and in with cell lines in a of at proliferation rate with to the which is a for cells. with and in for one for with and with and for by and the of the in with the cell cycle to the in and to for or with for and with in and with for with and the with and K.H. Choi Lee Kim Kim J.B. effects in of and 2006; PubMed Scopus Google RNA with of RNA to synthesis by reverse The of by and to the The that for the are in I. RNA (siRNA) for and FAS by and from RWPE1 with to the The for is in The with and and to as (13Choe S.S. Choi A.H. Lee J.W. Kim K.H. Chung J.J. Park J. Lee K.M. Park K.G. Lee I.K. Kim J.B. Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic beta-cells.Diabetes. 2007; 56: 1534-1543Crossref PubMed Scopus (83) Google Scholar). of the by and to the with and with The in and which by The by of SREBP1c as an The results with and enhanced by activated LXR is involved in cell T0901317, a synthetic LXR ligand, into cell and we proliferation in the proliferation of certain cells, such as RWPE1, THP1, SNU16, LNCaP, and inhibited by activated LXR with the proliferation of PC3, HEK293, and HeLa not by T0901317 results of which is a to the of cells, also that cell proliferation of RWPE1 and LNCaP, but not PC3, by LXR ligand implying that effect of LXR activation on cell proliferation to be in certain cell types. have reported that a of T0901317 is to stimulate other nuclear hormone such as and T0901317 is potent in LXR K.M. Thomas J.S. T0901317 is a 2004; PubMed Scopus Google Scholar, N. L. R. A. Saez E. T0901317 is a potent for the to 2007; PubMed Scopus Google Scholar). the effect of T0901317 on cell proliferation is mediated by activated LXR, we another LXR GW3965 has been developed as a ligand for LXR, and it the of other nuclear hormone including and (14Collins J.L. Fivush A.M. Watson M.A. Galardi C.M. Lewis M.C. Moore L.B. Parks D.J. Wilson J.G. Tippin T.K. Binz J.G. et al.Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines.J. Med. Chem. 2002; 45: 1963-1966Crossref PubMed Scopus (371) Google Scholar). GW3965 to RWPE1 cells, cell proliferation in a we antiproliferative activity of GW3965 in that activation of LXR would cell growth and proliferation in certain cells. LXR activation the proliferation rate in certain cells, we LXR activation would cell cycle we the cell cycle via we that LXR ligand T0901317 the in the and the in the in RWPE1, THP1, SNU16, and T0901317 and GW3965 arrested at G1/S boundary in a However, LXR activation did not the cell cycle in PC3, HEK293, or HeLa results suggest that activation of LXR in certain cell would cell cycle progression into the by G1/S to of cell proliferation in certain cell types. activation of LXR antiproliferative effects in certain cells, but not in cell types, we that activated LXR regulate target gene expression on cell by the of target gene expression on LXR ligands in cells. In RWPE1, THP1, SNU16, LNCaP, and by activated LXR, LXR target genes, including ABCA1, ABCG1, and upregulated by the LXR However, in and HeLa cells, expression of LXR target genes by LXR activation Interestingly, proliferation of not by the LXR ligand, expression of and by the LXR ligand in cells. However, the of SREBP1c and FAS not by the LXR ligand in cells. results that expression of fatty acid genes, such as SREBP1c and to be with the suppression of cell proliferation by LXR activation cholesterol LXR a key in cholesterol and fatty acid metabolism. Recently, it has been that LXR is to T cell proliferation through regulation of LXR-dependent sterol metabolism Bradley M.N. Joseph S.B. N. M.A. R. Parks J.S. P.A. et sterol metabolism to proliferation in the immune response.Cell. Full Text Full Text PDF PubMed Scopus Google Scholar). In T cells, induction of is for effects of LXR, and with a for antiproliferative of LXR proliferation of RWPE1 by LXR we RWPE1 with in the or of LXR such as T0901317 and GW3965, to of cholesterol metabolism be involved in the effect of LXR activation on cell proliferation. T cells, did not the effect of the LXR ligands on cell proliferation that of did not reverse the cell cycle arrest by LXR even in a data suggest that regulation of cholesterol metabolism by LXR activation be independent of cell for T cells. we lipogenic activity of activated LXR is with an antiproliferative In RWPE1 cells, T0901317 and GW3965 with the induction of de novo fatty acid synthesis by the of such as and cholesterol other cell including and triacylglyceride accumulation upon LXR activation the HeLa and cells, which are cell for the antiproliferative action of LXR, did not lipid accumulation that lipogenic activity by LXR activation to a key in the antiproliferative lipogenic stimulation upon LXR it is known that are LXR target is SREBP1c which is a key for several lipogenic genes, such as and as as J.B. P. M. Yao K.M. E. G. and regulation of fatty acid and gene expression through 1998; PubMed Scopus Google Scholar, J.B. promotes and gene expression to fatty acid 1996; PubMed Scopus Google Scholar, P. Kim J.B. R.A. a novel with and Cell. Biol. PubMed Scopus Google Scholar, K.H. M.J. S.S. Park S.D. Kim J.B. of synthase for activity of Biol. Chem. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). The other is which directly the synthesis of fatty and known to be in LXR-dependent and S.B. Laffitte B.A. Patel P.H. Watson M.A. Matsukuma K.E. Walczak R. Collins J.L. Osborne T.F. Tontonoz P. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors.J. Biol. Chem. 2002; 277: 11019-11025Abstract Full Text Full Text PDF PubMed Scopus (626) Google Scholar). SREBP1c FAS be a key for cell cycle arrest by LXR we these genes via of and FAS and suppression of via did not the antiproliferative of activated LXR, suppression of FAS via but the cell proliferation activity in the of LXR ligands Consistent with these the of with in cells, but not in other and and FAS and on target gene expression, cell and lipid we results data that FAS be to the effect of activated LXR-dependent cell cycle arrest in certain cells. these we not the that SREBP1c is not involved in activated LXR-dependent due to the of suppression of via cycle regulation is by key cell genes, such as and the molecular of LXR-dependent cell cycle arrest in cells, we the of several cell and target genes by with and For gene expression we with cells, these activated and The of A and selectively by activated LXR in in of other such as and whereas of in In accordance with these findings, the protein of A by the LXR ligand in cells, but the protein not in other such as and we the expression of genes, such as and in of cells. these we also gene expression in RWPE1 and results to that A and be potential to activated in certain cell types. In this study, we the effect of LXR activation on cell proliferation and cell cycle that LXR proliferation of certain through G1/S whereas the proliferation of other cell such as PC3, HEK293, and not by LXR stimulation expression in that expression of lipogenic genes closely with the antiproliferative effect of activated LXR Furthermore, of FAS activated cell growth arrest However, the involved in LXR-dependent cell cycle to be Interestingly, of data suggest that the regulation of fatty acid metabolism by LXR activation contributes to cell cycle PC3, HEK293, and HeLa cells, which are to activated LXR-dependent antiproliferative to expression of lipogenic genes such as SREBP1c and even though to expression of cholesterol genes the of in the of LXR ligands only elevated in activated LXR-dependent cell of which is a of did not the RWPE1 from activated cell cycle arrest suppression of FAS via partially the effect of activated LXR on cell proliferation implying that of FAS be important for activated cell cycle at in of FAS would cell cycle we the with a FAS However, we to potent which is in J.A. L. I. R. R. of fatty acid synthase (FAS) suppresses in cancer Natl. Acad. Sci. USA. 2004; PubMed Scopus Google Scholar, acid synthase in human cancer leads to of fatty acid and 2001; PubMed Scopus Google Scholar, and activity of an of fatty acid Natl. Acad. Sci. USA. PubMed Scopus Google Scholar, Y. T. H. N. T. H. I. et acid synthase is a novel target in J. PubMed Scopus Google Scholar). reports have that would be a for an due to its potent antiproliferative J.A. L. I. R. R. of fatty acid synthase (FAS) suppresses in cancer Natl. Acad. Sci. USA. 2004; PubMed Scopus Google Scholar, acid synthase in human cancer leads to of fatty acid and 2001; PubMed Scopus Google Scholar, and activity of an of fatty acid Natl. Acad. Sci. USA. PubMed Scopus Google Scholar, Y. T. H. N. T. H. I. et acid synthase is a novel target in J. PubMed Scopus Google Scholar). that LXR-dependent is by several mechanisms on cell and Consistent with have reported that LXR is involved in in several (17Blaschke F. Leppanen O. Takata Y. Caglayan E. Liu J. Fishbein M.C. Kappert K. Collins E. et X receptor smooth muscle cell proliferation and in 2004; PubMed Google Scholar, W. H. J. A.M. Activation of liver X receptors and X receptors induces growth arrest and apoptosis in insulin-secreting 2007; PubMed Scopus Google Scholar, R.A. J.M. J. Chen of growth and progression of cancer in mice by and liver X receptor 2006; PubMed Scopus Google Scholar, J. J.M. R.A. effect of liver X receptor on human cancer 2004; PubMed Scopus Google Scholar, J. J.J. L. X. Activation of liver X receptors inhibits pancreatic beta cell proliferation through cell cycle PubMed Scopus Google Scholar). In T cells, LXR activation inhibits cell proliferation via cholesterol metabolism Bradley M.N. Joseph S.B. N. M.A. R. Parks J.S. P.A. et sterol metabolism to proliferation in the immune response.Cell. Full Text Full Text PDF PubMed Scopus Google Scholar). In LXR cell cycle arrest by in smooth muscle cells, pancreatic and cancer (17Blaschke F. Leppanen O. Takata Y. Caglayan E. Liu J. Fishbein M.C. Kappert K. Collins E. et X receptor smooth muscle cell proliferation and in 2004; PubMed Google Scholar, J. J.J. L. X. Activation of liver X receptors inhibits pancreatic beta cell proliferation through cell cycle PubMed Scopus Google Scholar, J.M. R.A. of liver X receptor as novel for Sci. 2007; 14: PubMed Scopus Google Scholar). In this study, we did not of or protein in the of LXR ligand data not we that of de novo fatty acid synthesis to be for cell cycle by the results of regulation of LXR target genes and as as FAS is that elevated fatty acid lipotoxicity and even cell with G1/S arrest in certain A. O. effects of in PubMed Scopus Google Scholar, H. fatty Biol. Chem. 2006; Full Text Full Text PDF PubMed Scopus Google Scholar, A. R. fatty hepatic lipotoxicity by expression via a 2004; PubMed Scopus Google Scholar). For RWPE1, and pancreatic β-cells are for lipid and synthesis A. O. effects of in PubMed Scopus Google Scholar, I. fatty apoptosis in pancreatic Biol. Chem. 2002; 277: Full Text Full Text PDF PubMed Scopus Google Scholar, Chronic to fatty acid pancreatic beta cell by that is not for by a in 1998; PubMed Scopus Google and lipogenic activity leads to and apoptosis in these not Therefore, it is that lipid accumulation by lipogenic activity would be one of key mechanisms to the antiproliferative effect of LXR The antiproliferative of activated LXR is also to of A and A is for the and the C.H. T.K. A in cell cycle and Mol. Sci. 2002; PubMed Scopus Google Scholar, L. V. H. N. F. M. C. and nuclear PubMed Scopus Google Scholar, F. A. A is for the of in Full Text PDF PubMed Scopus Google Scholar). the of A is elevated in a of such as and cancer C.H. T.K. A in cell cycle and Mol. Sci. 2002; PubMed Scopus Google Scholar). to be is lipotoxicity and A regulation upon LXR activation in certain cells. is another cell gene a which is involved in the regulation of G1/S by and through of K. I. of the gene by the human 2001; PubMed Scopus Google Scholar, V. J.A. R. D. A rate of for with of PubMed Scopus Google Scholar). it is that of also contributes to the of cell cycle progression at the G1/S upon LXR However, the for cell cycle by LXR activation to be the of cell proliferation by LXRα and LXRβ, we the expression of LXRα and LXRβ in cell lines expressed of LXRα and LXRβ we did not LXRα or LXRβ expression and cell cycle we the effect of LXRα and LXRβ suppression via in RWPE1 cells. LXRα LXRβ in RWPE1 to in the of LXR we several LXRα and LXRβ and the of LXRα and LXRβ only Moreover, of LXRα and LXRβ did not the of LXR not we the antiproliferative effect of LXR activation in mouse embryonic from and knockout LXR activation with its ligands did not proliferation in the we did not of lipid on LXR ligands in not However, we that expression of several LXR target genes upregulated by LXR ligand in and LXRα even though we that LXR activation with elevated lipogenic activity to a in in certain cell types, are to LXRα LXRβ is for LXR-dependent we that LXR a in the regulation of cell proliferation as as LXR activation cell cycle progression in certain cell types, such as RWPE1, THP1, SNU16, LNCaP, and but not in such as PC3, HEK293, and HeLa cells. we that the of cell proliferation is with the lipogenic activity of results new for the of LXR on cell cycle with lipogenic with ATP-binding cassette apolipoprotein cyclooxygenase 2 cholesterol X receptor interleukin-6 lipopolysaccharide liver X receptor mouse embryonic inducible nitric oxide synthase X receptor small-interference RNA sterol regulatory element-binding protein

References

41